Next Article in Journal
Application of Chromatographic and Electrophoretic Methods for the Analysis of Imidazolium and Pyridinium Cations as Used in Ionic Liquids
Previous Article in Journal
Full Analytic Progress Curves of Enzymic Reactions in Vitro
Article Menu

Export Article

Open AccessArticle
Int. J. Mol. Sci. 2006, 7(11), 485-496; doi:10.3390/i7110485

Triazoloquinazolines as Human A3 Adenosine Receptor Antagonists: A QSAR Study

Systems Microbiology Research Center, KRIBB, Daejeon 305-806, Korea
Department of Biomicrosystem Technology, Korea University, Seoul 136-701, Korea
Department of Chemical and Biological Engineering, Korea University, Seoul 136-701, Korea
Authors to whom correspondence should be addressed.
Received: 11 October 2006 / Accepted: 3 November 2006 / Published: 15 November 2006
View Full-Text   |   Download PDF [1104 KB, uploaded 19 June 2014]   |  


Multiple linear regression analysis was performed on the quantitative structure-activity relationships (QSAR) of the triazoloquinazoline adenosine antagonists for human A3receptors. The data set used for the QSAR analysis encompassed the activities of 33triazoloquinazoline derivatives and 72 physicochemical descriptors. A template moleculewas derived using the known molecular structure for one of the compounds when bound tothe human A2B receptor, in which the amide bond was in a cis-conformation. All the testcompounds were aligned to the template molecule. In order to identify a reasonable QSARequation to describe the data set, we developed a multiple linear regression program thatexamined every possible combination of descriptors. The QSAR equation derived from thisanalysis indicates that the spatial and electronic effects is greater than that of hydrophobiceffects in binding of the antagonists to the human A3 receptor. It also predicts that a largesterimol length parameter is advantageous to activity, whereas large sterimol widthparameters and fractional positive partial surface areas are nonadvatageous. View Full-Text
Keywords: QSAR; triazoloquinazoline adenosine antagonist; human A3 receptor. QSAR; triazoloquinazoline adenosine antagonist; human A3 receptor.

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Kim, D.; Hong, S.-I.; Lee, D.-S. Triazoloquinazolines as Human A3 Adenosine Receptor Antagonists: A QSAR Study. Int. J. Mol. Sci. 2006, 7, 485-496.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top